Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus

被引：198
|
作者：
Volarevic, Vladislav [1 ]
Arsenijevic, Nebojsa [1 ]
Lukic, Miodrag L. [1 ,2 ]
Stojkovic, Miodrag [1 ,3 ]
机构：
[1] Univ Kragujevac, Ctr Mol Med, Fac Med, Kragujevac 34000, Serbia
[2] UAE Univ, Fac Med & Hlth Sci, Dept Microbiol & Immunol, Al Ain, U Arab Emirates
[3] Spebo Med, Leskovac 16000, Serbia
来源：
STEM CELLS | 2011年 / 29卷 / 01期
关键词：
Mesenchymal stem cell; Cardiomyopathy; Nephropathy; Neuropathy; Wound; Diabetes mellitus; INSULIN-PRODUCING CELLS; MULTIPOTENT STROMAL CELLS; MURINE BONE-MARROW; IN-VITRO; GROWTH-FACTOR; HEART-RATE; RATS; MICE; DIFFERENTIATION; STREPTOZOTOCIN;
D O I：
10.1002/stem.556
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Mesenchymal stem cells (MSCs) are multipotent, self-renewing cells that can be found in almost all postnatal organs and tissues. The main functional characteristics of MSCs are their immunomodulatory ability, capacity for self-renewal, and differentiation into mesodermal tissues. The ability of MSCs to differentiate into several cell types, including muscle, brain, vascular, skin, cartilage, and bone cells, makes them attractive as therapeutic agents for a number of diseases including complications of diabetes mellitus. We review here the potential of MSCs as new therapeutic agents in the treatment of diabetic cardiomyopathy, diabetic nephropathy, diabetic polyneuropathy, diabetic retinopathy, and diabetic wounds. Also, in this review we discuss the current limitations for MSCs therapy in humans. STEM CELLS 2011;29:5-10
引用
收藏
页码：5 / 10
页数：6
相关论文
共 50 条
  • [31] Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy
    van de Vyver, Mari
    STEM CELLS AND DEVELOPMENT, 2017, 26 (14) : 1042 - 1053
  • [32] Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock?
    Laroye, Caroline
    Gibot, Sebastien
    Reppel, Loic
    Le Bensoussan, Danie
    STEM CELLS, 2017, 35 (12) : 2331 - 2339
  • [33] Diabetes mellitus and oxidative stress-A concise review
    Ullah, Asmat
    Khan, Abad
    Khan, Ismail
    SAUDI PHARMACEUTICAL JOURNAL, 2016, 24 (05) : 547 - 553
  • [34] Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease
    Ward, Michael R.
    Abadeh, Armin
    Connelly, Kim A.
    STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (07) : 543 - 550
  • [35] The Clinical Trials of Mesenchymal Stem Cell Therapy in Skin Diseases: An Update and Concise Review
    Golchin, Ali
    Farahany, Tahereh Z.
    Khojasteh, Arash
    Soleimanifar, Fatemeh
    Ardeshirylajimi, Abdolreza
    CURRENT STEM CELL RESEARCH & THERAPY, 2019, 14 (01) : 22 - 33
  • [36] Concise Review: The Bystander Effect: Mesenchymal Stem Cell-Mediated Lung Repair
    Savukinas, Ulrika Blank
    Enes, Sara Rolandsson
    Sjoland, Annika Andersson
    Westergren-Thorsson, Gunilla
    STEM CELLS, 2016, 34 (06) : 1437 - 1444
  • [37] Concise Review: Different Mesenchymal Stromal/Stem Cell Populations Reside in the Adult Kidney
    Bruno, Stefania
    Chiabotto, Giulia
    Camussi, Giovanni
    STEM CELLS TRANSLATIONAL MEDICINE, 2014, 3 (12) : 1451 - 1455
  • [38] The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus
    Kim, Ju-El
    Lee, Jong-Won
    Cha, Gi Doo
    Yoon, Jeong-Kee
    BIOMIMETICS, 2025, 10 (01)
  • [39] Autologous Mesenchymal Stem Cell Transplant in Patients with Type 1 Diabetes Mellitus
    Ulyanova, Olga
    Askarov, Manarbek
    Kozina, Larissa
    Karibekov, Temirlan
    Shaimardanova, Galiya
    Zhakupova, Aigerim
    Danilova, Diana
    Serebrennikova, Dina
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 : 236 - 238
  • [40] A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus
    Cho, Jang
    D'Antuono, Matthew
    Glicksman, Michael
    Wang, Jing
    Jonklaas, Jacqueline
    AMERICAN JOURNAL OF STEM CELLS, 2018, 7 (04): : 82 - 93
12345